Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study.
Fabi A, Metro G, Vidiri A, Lanzetta G, Carosi M, Telera S, Maschio M, Russillo M, Sperduti I, Carapella CM, Cognetti F, Pace A.
Fabi A, et al. Among authors: carapella cm.
J Neurooncol. 2010 Nov;100(2):209-15. doi: 10.1007/s11060-010-0163-3. Epub 2010 Mar 30.
J Neurooncol. 2010.
PMID: 20352471
Clinical Trial.